Alzheimer's Disease
|
0.300 |
Biomarker
|
disease |
CTD_human |
MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease.
|
25992776 |
2015 |
Presenile dementia
|
0.300 |
Biomarker
|
disease |
CTD_human |
MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease.
|
25992776 |
2015 |
Hepatitis, Toxic
|
0.300 |
Biomarker
|
disease |
CTD_human |
"Serum microRNA signatures as ""liquid biopsies"" for interrogating hepatotoxic mechanisms and liver pathogenesis in human."
|
28545106 |
2017 |
Hepatoma, Morris
|
0.300 |
Biomarker
|
disease |
CTD_human |
Circulating microRNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages.
|
21035526 |
2011 |
Hepatoma, Novikoff
|
0.300 |
Biomarker
|
disease |
CTD_human |
Circulating microRNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages.
|
21035526 |
2011 |
Experimental Hepatoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Circulating microRNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages.
|
21035526 |
2011 |
Familial Alzheimer Disease (FAD)
|
0.300 |
Biomarker
|
disease |
CTD_human |
MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease.
|
25992776 |
2015 |
Alzheimer Disease, Late Onset
|
0.300 |
Biomarker
|
disease |
CTD_human |
MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease.
|
25992776 |
2015 |
Acute Confusional Senile Dementia
|
0.300 |
Biomarker
|
disease |
CTD_human |
MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease.
|
25992776 |
2015 |
Alzheimer's Disease, Focal Onset
|
0.300 |
Biomarker
|
disease |
CTD_human |
MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease.
|
25992776 |
2015 |
Alzheimer Disease, Early Onset
|
0.300 |
Biomarker
|
disease |
CTD_human |
MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease.
|
25992776 |
2015 |
Hepatitis, Drug-Induced
|
0.300 |
Biomarker
|
disease |
CTD_human |
"Serum microRNA signatures as ""liquid biopsies"" for interrogating hepatotoxic mechanisms and liver pathogenesis in human."
|
28545106 |
2017 |
Drug-Induced Acute Liver Injury
|
0.300 |
Biomarker
|
disease |
CTD_human |
"Serum microRNA signatures as ""liquid biopsies"" for interrogating hepatotoxic mechanisms and liver pathogenesis in human."
|
28545106 |
2017 |
Chemical and Drug Induced Liver Injury
|
0.300 |
Biomarker
|
disease |
CTD_human |
"Serum microRNA signatures as ""liquid biopsies"" for interrogating hepatotoxic mechanisms and liver pathogenesis in human."
|
28545106 |
2017 |
Chemically-Induced Liver Toxicity
|
0.300 |
Biomarker
|
disease |
CTD_human |
"Serum microRNA signatures as ""liquid biopsies"" for interrogating hepatotoxic mechanisms and liver pathogenesis in human."
|
28545106 |
2017 |
Malignant neoplasm of stomach
|
0.030 |
Biomarker
|
disease |
BEFREE |
Association between functional PSMD10 Rs111638916 variant regulated by MiR-505 and gastric cancer risk in a Chinese population.
|
26394032 |
2015 |
Malignant neoplasm of stomach
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Overexpression of miR-505 was able to repress GC progression in AGS and BGC-823 cells.
|
30525214 |
2018 |
Malignant neoplasm of stomach
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
These findings indicated that miR-505 expression is downregulated in both GC cell lines and GC tissues.
|
30774367 |
2019 |
Cervix carcinoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
The expression levels of lncRNA-CTS and miR-505 were detected using quantitative reverse transcriptase polymerase chain reaction in CC specimens and cells (HeLa, SiHa, Ca-Ski, C-33A, and HT-3).
|
31499118 |
2019 |
Cervix carcinoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
FDZ4 is reversely expressed as miR-505, and has dramatic regulatory function in cervical cancer.
|
28577497 |
2017 |
Cervix carcinoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Cell counting kit-8 (CCK-8) assay, Scratch wound healing assay and transwell assay were used to detect the roles of miR-505-5p and CDK5 in CC cell functions.
|
31266812 |
2019 |
Stomach Carcinoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Association between functional PSMD10 Rs111638916 variant regulated by MiR-505 and gastric cancer risk in a Chinese population.
|
26394032 |
2015 |
Stomach Carcinoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
These findings indicated that miR-505 expression is downregulated in both GC cell lines and GC tissues.
|
30774367 |
2019 |
Stomach Carcinoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Overexpression of miR-505 was able to repress GC progression in AGS and BGC-823 cells.
|
30525214 |
2018 |
Malignant neoplasm of breast
|
0.020 |
Biomarker
|
disease |
BEFREE |
Additionally, miR-505-3p inhibited runt-related transcription factor 2 (RUNX2) expression by directly bind to its 3'- untranslated region (3'-UTR) and overexpression of RUNX2 partially reversed the effect of miR-505-3p mimics on BC cell proliferation and invasion.
|
31705901 |
2019 |